Free Trial
NASDAQ:HSDT

Helius Medical Technologies Q4 2024 Earnings Report

Helius Medical Technologies logo
$3.56 -0.15 (-4.04%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Helius Medical Technologies EPS Results

Actual EPS
-$15.45
Consensus EPS
-$14.10
Beat/Miss
Missed by -$1.35
One Year Ago EPS
N/A

Helius Medical Technologies Revenue Results

Actual Revenue
$0.15 million
Expected Revenue
$0.10 million
Beat/Miss
Beat by +$50.00 thousand
YoY Revenue Growth
N/A

Helius Medical Technologies Announcement Details

Quarter
Q4 2024
Time
Before Market Opens
Conference Call Date
Monday, March 24, 2025
Conference Call Time
7:00PM ET

Upcoming Earnings

Helius Medical Technologies' Q2 2025 earnings is scheduled for Monday, August 11, 2025, with a conference call scheduled at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Earnings Documents

Helius Medical Technologies Earnings Headlines

F1 Engineering Powers This Electric Marine Motor
The future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLaren Engineering, a NASDAQ-listed marine tech company unveiled a groundbreaking new electric powertrain set to transform the industry.
See More Helius Medical Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Helius Medical Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Helius Medical Technologies and other key companies, straight to your email.

About Helius Medical Technologies

Helius Medical Technologies (NASDAQ:HSDT), a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.

View Helius Medical Technologies Profile

More Earnings Resources from MarketBeat